TY - JOUR AU - Larson, S. M. AU - Carrasquillo, J. A. AU - Cheung, N. K. AU - Press, O. W. PY - 2015 DA - 2015// TI - Radioimmunotherapy of human tumours JO - Nat Rev Cancer. VL - 15 UR - https://doi.org/10.1038/nrc3925 DO - 10.1038/nrc3925 ID - Larson2015 ER - TY - JOUR AU - Brambell, F. W. PY - 1966 DA - 1966// TI - The transmission of immunity from mother to young and the catabolism of immunoglobulins JO - Lancet. VL - 2 UR - https://doi.org/10.1016/S0140-6736(66)92190-8 DO - 10.1016/S0140-6736(66)92190-8 ID - Brambell1966 ER - TY - JOUR AU - Roopenian, D. C. AU - Christianson, G. J. AU - Sproule, T. J. AU - Brown, A. C. AU - Akilesh, S. AU - Jung, N. PY - 2003 DA - 2003// TI - The MHC class I-like IgG receptor controls perinatal IgG transport, IgG homeostasis, and fate of IgG-Fc-coupled drugs JO - J Immunol. VL - 170 UR - https://doi.org/10.4049/jimmunol.170.7.3528 DO - 10.4049/jimmunol.170.7.3528 ID - Roopenian2003 ER - TY - JOUR AU - Junghans, R. P. AU - Anderson, C. L. PY - 1996 DA - 1996// TI - The protection receptor for IgG catabolism is the beta2-microglobulin-containing neonatal intestinal transport receptor JO - Proc Natl Acad Sci U S A. VL - 93 UR - https://doi.org/10.1073/pnas.93.11.5512 DO - 10.1073/pnas.93.11.5512 ID - Junghans1996 ER - TY - JOUR AU - Ghetie, V. AU - Hubbard, J. G. AU - Kim, J. K. AU - Tsen, M. F. AU - Lee, Y. AU - Ward, E. S. PY - 1996 DA - 1996// TI - Abnormally short serum half-lives of IgG in beta 2-microglobulin-deficient mice JO - Eur J Immunol. VL - 26 UR - https://doi.org/10.1002/eji.1830260327 DO - 10.1002/eji.1830260327 ID - Ghetie1996 ER - TY - JOUR AU - Simister, N. E. AU - Mostov, K. E. PY - 1989 DA - 1989// TI - An Fc receptor structurally related to MHC class I antigens JO - Nature. VL - 337 UR - https://doi.org/10.1038/337184a0 DO - 10.1038/337184a0 ID - Simister1989 ER - TY - JOUR AU - Stein, R. AU - Govindan, S. V. AU - Chen, S. AU - Reed, L. AU - Richel, H. AU - Griffiths, G. L. PY - 2001 DA - 2001// TI - Radioimmunotherapy of a human lung cancer xenograft with monoclonal antibody RS7: evaluation of (177)Lu and comparison of its efficacy with that of (90)Y and residualizing (131)I JO - J Nucl Med. VL - 42 ID - Stein2001 ER - TY - JOUR AU - Press, O. W. AU - Shan, D. AU - Howell-Clark, J. AU - Eary, J. AU - Appelbaum, F. R. AU - Matthews, D. PY - 1996 DA - 1996// TI - Comparative metabolism and retention of iodine-125, yttrium-90, and indium-111 radioimmunoconjugates by cancer cells JO - Cancer Res. VL - 56 ID - Press1996 ER - TY - JOUR AU - Naruki, Y. AU - Carrasquillo, J. A. AU - Reynolds, J. C. AU - Maloney, P. J. AU - Frincke, J. M. AU - Neumann, R. D. PY - 1990 DA - 1990// TI - Differential cellular catabolism of 111In, 90Y and 125I radiolabeled T101 anti-CD5 monoclonal antibody JO - Int J Rad Appl Instrum B. VL - 17 UR - https://doi.org/10.1016/0883-2897(90)90148-T DO - 10.1016/0883-2897(90)90148-T ID - Naruki1990 ER - TY - JOUR AU - Holliger, P. AU - Hudson, P. J. PY - 2005 DA - 2005// TI - Engineered antibody fragments and the rise of single domains JO - Nat Biotechnol. VL - 23 UR - https://doi.org/10.1038/nbt1142 DO - 10.1038/nbt1142 ID - Holliger2005 ER - TY - CHAP AU - Burvenich, I. J. G. AU - Scott, A. M. ED - Speer, T. W. PY - 2011 DA - 2011// TI - The delivery construct: maximizing the therapeutic ratio of targeted radionuclide therapy BT - Targeted radionuclide therapy PB - Wilkins CY - Philadelphia ID - Burvenich2011 ER - TY - JOUR AU - Clarke, K. AU - Lee, F. T. AU - Brechbiel, M. W. AU - Smyth, F. E. AU - Old, L. J. AU - Scott, A. M. PY - 2000 DA - 2000// TI - In vivo biodistribution of a humanized anti-Lewis Y monoclonal antibody (hu3S193) in MCF-7 xenografted BALB/c nude mice JO - Cancer Res. VL - 60 ID - Clarke2000 ER - TY - JOUR AU - Tahtis, K. AU - Lee, F. T. AU - Smyth, F. E. AU - Power, B. E. AU - Renner, C. AU - Brechbiel, M. W. PY - 2001 DA - 2001// TI - Biodistribution properties of (111)indium-labeled C-functionalized trans-cyclohexyl diethylenetriaminepentaacetic acid humanized 3S193 diabody and F(ab')(2) constructs in a breast carcinoma xenograft model JO - Clin Cancer Res. VL - 7 ID - Tahtis2001 ER - TY - JOUR AU - Kelly, M. P. AU - Lee, F. T. AU - Tahtis, K. AU - Power, B. E. AU - Smyth, F. E. AU - Brechbiel, M. W. PY - 2008 DA - 2008// TI - Tumor targeting by a multivalent single-chain Fv (scFv) anti-Lewis Y antibody construct JO - Cancer Biother Radiopharm. VL - 23 UR - https://doi.org/10.1089/cbr.2007.0450 DO - 10.1089/cbr.2007.0450 ID - Kelly2008 ER - TY - JOUR AU - Goodwin, D. A. AU - Meares, C. F. AU - Osen, M. PY - 1998 DA - 1998// TI - Biological properties of biotin-chelate conjugates for pretargeted diagnosis and therapy with the avidin/biotin system JO - J Nucl Med. VL - 39 ID - Goodwin1998 ER - TY - JOUR AU - Kim, J. K. AU - Firan, M. AU - Radu, C. G. AU - Kim, C. H. AU - Ghetie, V. AU - Ward, E. S. PY - 1999 DA - 1999// TI - Mapping the site on human IgG for binding of the MHC class I-related receptor JO - FcRn. Eur J Immunol. VL - 29 UR - https://doi.org/3.0.CO;2-6 DO - 3.0.CO;2-6 ID - Kim1999 ER - TY - JOUR AU - Martin, W. L. AU - West, A. P. AU - Gan, L. AU - Bjorkman, P. J. PY - 2001 DA - 2001// TI - Crystal structure at 2.8 A of an FcRn/heterodimeric Fc complex: mechanism of pH-dependent binding JO - Mol Cell VL - 7 UR - https://doi.org/10.1016/S1097-2765(01)00230-1 DO - 10.1016/S1097-2765(01)00230-1 ID - Martin2001 ER - TY - JOUR AU - Shields, R. L. AU - Namenuk, A. K. AU - Hong, K. AU - Meng, Y. G. AU - Rae, J. AU - Briggs, J. PY - 2001 DA - 2001// TI - High resolution mapping of the binding site on human IgG1 for Fc gamma RI, Fc gamma RII, Fc gamma RIII, and FcRn and design of IgG1 variants with improved binding to the Fc gamma R JO - J Biol Chem. VL - 276 UR - https://doi.org/10.1074/jbc.M009483200 DO - 10.1074/jbc.M009483200 ID - Shields2001 ER - TY - JOUR AU - Roopenian, D. C. AU - Akilesh, S. PY - 2007 DA - 2007// TI - FcRn: the neonatal Fc receptor comes of age JO - Nat Rev Immunol. VL - 7 UR - https://doi.org/10.1038/nri2155 DO - 10.1038/nri2155 ID - Roopenian2007 ER - TY - JOUR AU - Kenanova, V. AU - Olafsen, T. AU - Crow, D. M. AU - Sundaresan, G. AU - Subbarayan, M. AU - Carter, N. H. PY - 2005 DA - 2005// TI - Tailoring the pharmacokinetics and positron emission tomography imaging properties of anti-carcinoembryonic antigen single-chain Fv-Fc antibody fragments JO - Cancer Res VL - 65 ID - Kenanova2005 ER - TY - JOUR AU - Kenanova, V. AU - Olafsen, T. AU - Williams, L. E. AU - Ruel, N. H. AU - Longmate, J. AU - Yazaki, P. J. PY - 2007 DA - 2007// TI - Radioiodinated versus radiometal-labeled anti-carcinoembryonic antigen single-chain Fv-Fc antibody fragments: optimal pharmacokinetics for therapy JO - Cancer Res VL - 67 UR - https://doi.org/10.1158/0008-5472.CAN-06-0454 DO - 10.1158/0008-5472.CAN-06-0454 ID - Kenanova2007 ER - TY - JOUR AU - Olafsen, T. AU - Betting, D. AU - Kenanova, V. E. AU - Salazar, F. B. AU - Clarke, P. AU - Said, J. PY - 2009 DA - 2009// TI - Recombinant anti-CD20 antibody fragments for small-animal PET imaging of B-cell lymphomas JO - J Nucl Med. VL - 50 UR - https://doi.org/10.2967/jnumed.108.060426 DO - 10.2967/jnumed.108.060426 ID - Olafsen2009 ER - TY - JOUR AU - Girgis, M. D. AU - Olafsen, T. AU - Kenanova, V. AU - McCabe, K. E. AU - Wu, A. M. AU - Tomlinson, J. S. PY - 2011 DA - 2011// TI - Targeting CEA in pancreas cancer xenografts with a mutated scFv-Fc antibody fragment JO - EJNMMI Res. VL - 1 UR - https://doi.org/10.1186/2191-219X-1-24 DO - 10.1186/2191-219X-1-24 ID - Girgis2011 ER - TY - JOUR AU - Hornick, J. L. AU - Sharifi, J. AU - Khawli, L. A. AU - Hu, P. AU - Bai, W. G. AU - Alauddin, M. M. PY - 2000 DA - 2000// TI - Single amino acid substitution in the Fc region of chimeric TNT-3 antibody accelerates clearance and improves immunoscintigraphy of solid tumors JO - J Nucl Med. VL - 41 ID - Hornick2000 ER - TY - STD TI - Burvenich IJG, Farrugia W, Lee FT, Catimel B, Liu Z, Makris D, et al. Cross-species analysis of Fc engineered anti-Lewis-Y human IgG1 variants in human neonatal receptor transgenic mice reveal importance of S254 and Y436 in binding human neonatal Fc receptor. MAbs, in press ID - ref25 ER - TY - JOUR AU - Clarke, K. AU - Lee, F. T. AU - Brechbiel, M. W. AU - Smyth, F. E. AU - Old, L. J. AU - Scott, A. M. PY - 2000 DA - 2000// TI - Therapeutic efficacy of anti-Lewis(y) humanized 3S193 radioimmunotherapy in a breast cancer model: enhanced activity when combined with taxol chemotherapy JO - Clin Cancer Res. VL - 6 ID - Clarke2000 ER - TY - JOUR AU - Lee, F. T. AU - Mountain, A. J. AU - Kelly, M. P. AU - Hall, C. AU - Rigopoulos, A. AU - Johns, T. G. PY - 2005 DA - 2005// TI - Enhanced efficacy of radioimmunotherapy with 90Y-CHX-A''-DTPA-hu3S193 by inhibition of epidermal growth factor receptor (EGFR) signaling with EGFR tyrosine kinase inhibitor AG1478 JO - Clin Cancer Res VL - 11 UR - https://doi.org/10.1158/1078-0432.CCR-1004-0019 DO - 10.1158/1078-0432.CCR-1004-0019 ID - Lee2005 ER - TY - JOUR AU - Kelly, M. P. AU - Lee, F. T. AU - Smyth, F. E. AU - Brechbiel, M. W. AU - Scott, A. M. PY - 2006 DA - 2006// TI - Enhanced efficacy of 90Y-radiolabeled anti-Lewis Y humanized monoclonal antibody hu3S193 and paclitaxel combined-modality radioimmunotherapy in a breast cancer model JO - J Nucl Med. VL - 47 ID - Kelly2006 ER - TY - JOUR AU - Kelly, M. P. AU - Lee, S. T. AU - Lee, F. T. AU - Smyth, F. E. AU - Davis, I. D. AU - Brechbiel, M. W. PY - 2009 DA - 2009// TI - Therapeutic efficacy of 177Lu-CHX-A''-DTPA-hu3S193 radioimmunotherapy in prostate cancer is enhanced by EGFR inhibition or docetaxel chemotherapy JO - Prostate. VL - 69 UR - https://doi.org/10.1002/pros.20856 DO - 10.1002/pros.20856 ID - Kelly2009 ER - TY - JOUR AU - Scott, A. M. AU - Tebbutt, N. AU - Lee, F. T. AU - Cavicchiolo, T. AU - Liu, Z. AU - Gill, S. PY - 2007 DA - 2007// TI - A phase I biodistribution and pharmacokinetic trial of humanized monoclonal antibody Hu3s193 in patients with advanced epithelial cancers that express the Lewis-Y antigen JO - Clin Cancer Res. VL - 13 UR - https://doi.org/10.1158/1078-0432.CCR-07-0284 DO - 10.1158/1078-0432.CCR-07-0284 ID - Scott2007 ER - TY - JOUR AU - Scott, A. M. AU - Geleick, D. AU - Rubira, M. AU - Clarke, K. AU - Nice, E. C. AU - Smyth, F. E. PY - 2000 DA - 2000// TI - Construction, production, and characterization of humanized anti-Lewis Y monoclonal antibody 3S193 for targeted immunotherapy of solid tumors JO - Cancer Res. VL - 60 ID - Scott2000 ER - TY - JOUR AU - Scott, A. M. AU - Lee, F. T. AU - Jones, R. AU - Hopkins, W. AU - MacGregor, D. AU - Cebon, J. S. PY - 2005 DA - 2005// TI - A phase I trial of humanized monoclonal antibody A33 in patients with colorectal carcinoma: biodistribution, pharmacokinetics, and quantitative tumor uptake JO - Clin Cancer Res. VL - 11 UR - https://doi.org/10.1158/1078-0432.CCR-04-2329 DO - 10.1158/1078-0432.CCR-04-2329 ID - Scott2005 ER - TY - JOUR AU - Lee, F. T. AU - O'Keefe, G. J. AU - Gan, H. K. AU - Mountain, A. J. AU - Jones, G. R. AU - Saunder, T. H. PY - 2010 DA - 2010// TI - Immuno-PET quantitation of de2-7 epidermal growth factor receptor expression in glioma using 124I-IMP-R4-labeled antibody ch806 JO - J Nucl Med. VL - 51 UR - https://doi.org/10.2967/jnumed.109.068395 DO - 10.2967/jnumed.109.068395 ID - Lee2010 ER - TY - JOUR AU - Nikula, T. K. AU - Curcio, M. J. AU - Brechbiel, M. W. AU - Gansow, O. A. AU - Finn, R. D. AU - Scheinberg, D. A. PY - 1995 DA - 1995// TI - A rapid, single vessel method for preparation of clinical grade ligand conjugated monoclonal antibodies JO - Nucl Med Biol. VL - 22 UR - https://doi.org/10.1016/0969-8051(94)00126-5 DO - 10.1016/0969-8051(94)00126-5 ID - Nikula1995 ER - TY - JOUR AU - Wu, C. AU - Kobayashi, H. AU - Sun, B. AU - Yoo, T. M. AU - Paik, C. H. AU - Gansow, O. A. PY - 1997 DA - 1997// TI - Stereochemical influence on the stability of radio-metal complexes in vivo. Synthesis and evaluation of the four stereoisomers of 2-(p-nitrobenzyl)-trans-CyDTPA JO - Bioorg Med Chem VL - 5 UR - https://doi.org/10.1016/S0968-0896(97)00130-2 DO - 10.1016/S0968-0896(97)00130-2 ID - Wu1997 ER - TY - JOUR AU - Lee, F. T. AU - Rigopoulos, A. AU - Hall, C. AU - Clarke, K. AU - Cody, S. H. AU - Smyth, F. E. PY - 2001 DA - 2001// TI - Specific localization, gamma camera imaging, and intracellular trafficking of radiolabelled chimeric anti-G(D3) ganglioside monoclonal antibody KM871 in SK-MEL-28 melanoma xenografts JO - Cancer Res. VL - 61 ID - Lee2001 ER - TY - JOUR AU - Shen, S. AU - Forero, A. AU - Meredith, R. F. AU - LoBuglio, A. F. PY - 2011 DA - 2011// TI - Biodistribution and dosimetry of In-111/Y-90-HuCC49ΔCh2 (IDEC-159) in patients with metastatic colorectal adenocarcinoma JO - Cancer Biother Radiopharm. VL - 26 UR - https://doi.org/10.1089/cbr.2010.0864 DO - 10.1089/cbr.2010.0864 ID - Shen2011 ER - TY - JOUR AU - Strand, J. AU - Nordeman, P. AU - Honarvar, H. AU - Altai, M. AU - Orlova, A. AU - Larhed, M. PY - 2015 DA - 2015// TI - Site-specific radioiodination of HER2-targeting affibody molecules using 4-iodophenethylmaleimide decreases renal uptake of radioactivity JO - ChemistryOpen. VL - 4 UR - https://doi.org/10.1002/open.201402097 DO - 10.1002/open.201402097 ID - Strand2015 ER - TY - JOUR AU - Ocean, A. J. AU - Pennington, K. L. AU - Guarino, M. J. AU - Sheikh, A. AU - Bekaii-Saab, T. AU - Serafini, A. N. PY - 2012 DA - 2012// TI - Fractionated radioimmunotherapy with (90) Y-clivatuzumab tetraxetan and low-dose gemcitabine is active in advanced pancreatic cancer: a phase 1 trial JO - Cancer. VL - 118 UR - https://doi.org/10.1002/cncr.27592 DO - 10.1002/cncr.27592 ID - Ocean2012 ER - TY - JOUR AU - Cheal, S. M. AU - Xu, H. AU - Guo, H. F. AU - Zanzonico, P. B. AU - Larson, S. M. AU - Cheung, N. K. PY - 2014 DA - 2014// TI - Preclinical evaluation of multistep targeting of diasialoganglioside GD2 using an IgG-scFv bispecific antibody with high affinity for GD2 and DOTA metal complex JO - Mol Cancer Ther. VL - 13 UR - https://doi.org/10.1158/1535-7163.MCT-13-0933 DO - 10.1158/1535-7163.MCT-13-0933 ID - Cheal2014 ER - TY - JOUR AU - Reilly, E. B. AU - Phillips, A. C. AU - Buchanan, F. G. AU - Kingsbury, G. AU - Zhang, Y. AU - Meulbroek, J. A. PY - 2015 DA - 2015// TI - Characterization of ABT-806, a humanized tumor-specific anti-EGFR monoclonal antibody JO - Mol Cancer Ther. VL - 14 UR - https://doi.org/10.1158/1535-7163.MCT-14-0820 DO - 10.1158/1535-7163.MCT-14-0820 ID - Reilly2015 ER - TY - JOUR AU - Duncan, J. R. AU - Behr, T. M. AU - DeNardo, S. J. PY - 1997 DA - 1997// TI - Intracellular fate of radiometals JO - J Nucl Med. VL - 38 ID - Duncan1997 ER -